CARRIE TRABUCCO: Open Payments
NPI 1689013369 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 62 payments from 13 companies in 2025. Trend: 2023 $1,961 · 2024 $1,092 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $243 |
| Novartis Pharmaceuticals Corporation | 25 | $140 |
| GENZYME CORPORATION | 5 | $140 |
| UCB, Inc. | 5 | $106 |
| PFIZER INC. | 2 | $57 |
| Chiesi USA, Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $21 |
Products named: SKYRIZI, RINVOQ, Bimzelx, COSENTYX, DUPIXENT, AYVAKIT, CIBINQO, FILSUVEZ.
Industry payments across NY — which companies pay providers there.
